Valproic acid and Dyskinesia - a phase IV clinical study of FDA data

Summary:

Dyskinesia is found among people who take Valproic acid, especially for people who are male, 2-9 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Valproic acid and have Dyskinesia. It is created by eHealthMe based on reports of 30,749 people who have side effects when taking Valproic acid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

30,749 people reported to have side effects when taking Valproic acid.
Among them, 285 people (0.93%) have Dyskinesia.

What is Valproic acid?

Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 31,097 Valproic acid users for its effectiveness, alternative drugs and more.

What is Dyskinesia?

Dyskinesia (abnormality or impairment of voluntary movement) is found to be associated with 2,140 drugs and 1,698 conditions by eHealthMe.

Number of Valproic acid and Dyskinesia reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Valproic acid and have Dyskinesia?

Check whether Dyskinesia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .

Related studies

How severe was Dyskinesia and when was it recovered:

Dyskinesia in Valproic acid

Expand to all the drugs that have ingredients of valproic acid:

Dyskinesia and drugs with ingredients of valproic acid (273 reports)

Alternative drugs to, pros and cons of Valproic acid:

Valproic acid (31,097 reports)

Common Valproic acid side effects:

Browse all side effects of Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dyskinesia treatments and more:

Dyskinesia (44,954 reports)

COVID vaccines that are related to Dyskinesia:

Common drugs associated with Dyskinesia:

All the drugs that are associated with Dyskinesia:

Dyskinesia (2,140 drugs)

Common conditions associated with Dyskinesia:

Parkinson's disease: 7,689 reports
Depression: 2,576 reports
Multiple sclerosis: 1,479 reports
Pain: 1,332 reports

All the conditions that are associated with Dyskinesia:

Dyskinesia (1,698 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valproic acid (the active ingredients of Valproic acid) and Valproic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.